Skip to main content

TIA Pipeline Accelerator Voucher 2019-2020 - Cancuravax

Project Member(s): Ralph, P.

Funding or Partner Organisation: Department of Innovation, Industry, Science & Research (National Collaborative Research Infrastructure Strategy)
Therapeutic Innovation Australia (Australian Therapeutic Pipeline)
Cancuravax Pty Ltd
Cancuravax Pty Ltd

Start year: 2021

Summary: Melanoma Cancer Vaccine Immunotherapy Production & Scaling for Commercialisation

FOR Codes: Medical molecular engineering of nucleic acids and proteins, Human Pharmaceutical Treatments (e.g. Antibiotics), Human pharmaceutical treatments